Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium monofluorophosphate (SMFP) is an inorganic compound and a fluoride anticaries agent primarily used in over-the-counter dental preparations such as toothpaste to prevent and treat dental cavities. It works by releasing fluoride ions through hydrolysis, which strengthens tooth enamel, inhibits bacterial growth, and reduces acid production that contributes to tooth decay. SMFP is water-soluble, odourless, and colourless. It was developed by a chemist at Procter & Gamble but patented for toothpaste use by Colgate-Palmolive. In addition to its primary use in oral care products for cavity prevention, it has also been used in some medications for osteoporosis[1][2][3][4][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium monofluorophosphate.